Related Experiment Videos

Differences in physician compliance with guideline on lipid profile determination within 24 h after acute myocardial

A Al Aqeel1, O A Mojiminiyi, R Al Dashti

  • 1Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait.

Insights

In myocardial infarction patients, low high-density lipoprotein (HDL) cholesterol was the primary lipid risk factor. Early lipid testing within 24 hours and HDL-focused interventions are recommended for secondary prevention.

Area of Science:

  • Cardiology
  • Clinical Lipidology
  • Public Health

Background:

  • Current guidelines recommend blood lipid testing within 24 hours of chest pain onset in myocardial infarction (MI) patients.
  • Understanding lipid profiles in MI patients is crucial for effective secondary prevention strategies.

Purpose of the Study:

  • To evaluate the adherence to and effectiveness of American College of Cardiology/American Heart Association guidelines for lipid testing in MI patients.
  • To identify key lipid abnormalities and risk factors in patients presenting with acute myocardial infarction (AMI).

Main Methods:

  • A cross-sectional observational study involving 83 MI patients in Kuwait.
  • Lipid profiles (Total Cholesterol, HDL, Triglycerides, LDL) were measured within 24 hours of chest pain onset.
  • Patients' adherence to National Cholesterol Education Program (NCEP) LDL targets and presence of metabolic syndrome were assessed.

Main Results:

  • A significant proportion of patients (70%) had low HDL cholesterol and a poor HDL:TC ratio, indicating impaired lipid metabolism.
  • Only 27% of patients met the NCEP guideline target for LDL cholesterol (<2.6 mmol/l).
  • Metabolic syndrome was prevalent, identified in 56 patients (67.5%).

Conclusions:

  • Low HDL cholesterol is identified as the predominant lipid risk factor in this cohort of MI patients in Kuwait.
  • Primary prevention should prioritize interventions aimed at increasing HDL levels.
  • Routine lipid profiling within 24 hours of admission and initiation of lipid-lowering therapy are recommended for secondary prevention.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...